Retractable Technologies Q2 FY26 operating loss unchanged at $5.1 million; domestic revenue drops 30.8% on-year
RVP•Management outlook
Management expects EU MDR certification to lift second-half international sales.
Other income and expense items
Tariff expense totaled $46,000, while the company recorded a $179,000 unrealized loss on debt securities.
Liquidity got a boost from a $6.4 million realized gain on equity sales.
Quarterly results and revenue decline
Retractable Technologies posted a GAAP operating loss of $5.1 million for Q2 2026, unchanged from a year earlier.
Revenue fell 31.1% year on year to $8.07 million, with domestic revenue down 30.8% as unit sales slid 35.1%.
International revenue dropped 32.2%, on lower EasyPoint needle sales; total unit sales fell 36.4%.
